SWI/SNFEP400

Benjamin J E Martin1, Eileen F Ablondi2, Christine Goglia2

  • 1Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA 02115, USA.

Cell
|November 3, 2023
PubMed
概括

一种新的SWI/SNF抑制剂揭示了染色体重塑的点,并确定了EP400/TIP60作为补偿机制. 这一发现预测了癌细胞对SWI/SNF抑制的敏感性,改善了治疗策略.